Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2014 7
2015 11
2016 15
2017 25
2018 14
2019 26
2020 39
2021 56
2022 67
2023 60
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study.
Tejera-Vaquerizo A, Gómez-Tomás Á, Jaka A, Toll A, Del Río M, Ferrándiz-Pulido C, Fuente MJ, Carrasco C, Almazán-Fernández FM, Toledo-Pastrana T, Ferrer-Fuertes A, Ribero S, Avallone G, Cañueto J, Santos-Juanes J, Sanmartín O. Tejera-Vaquerizo A, et al. Among authors: ribero s. J Eur Acad Dermatol Venereol. 2024 May 13. doi: 10.1111/jdv.20051. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38738666
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Cascio Ingurgio R, Malagoli P, Amoruso F, Balato A, Bardazzi F, Brianti P, Brunasso G, Burlando M, Cagni AE, Caproni M, Carrera CG, Carugno A, Caudullo F, Cuccia A, Dapavo P, Di Brizzi EV, Dini V, Gaiani FM, Gisondi P, Guarneri C, Lasagni C, Licata G, Loconsole F, Marzano AV, Megna M, Mercuri SR, Musumeci ML, Orsini D, Ribero S, Ruffo Di Calabria V, Satolli F, Strippoli D, Travaglini M, Trovato E, Venturini M, Zichichi L, Valenti M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: ribero s. J Dermatolog Treat. 2024 Dec;35(1):2350760. doi: 10.1080/09546634.2024.2350760. Epub 2024 May 7. J Dermatolog Treat. 2024. PMID: 38714323 Free article.
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.
Nazzaro G, Carugno A, Bortoluzzi P, Buffon S, Astrua C, Zappia E, Trovato E, Caccavale S, Pellegrino V, Paolino G, Balestri R, Lacava R, Ciccarese G, Verdelli A, Barruscotti S, Valenti M, Toni G, Giacalone S, Zavattaro E, Gironi LC, Mercuri SR, Ribero S, Gisondi P, Sena P, Marzano AV. Nazzaro G, et al. Among authors: ribero s. Int J Dermatol. 2024 Apr 11. doi: 10.1111/ijd.17168. Online ahead of print. Int J Dermatol. 2024. PMID: 38605473 Free article.
Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk.
Boskovic S, Borriello S, D'Ascenzo F, Sciamarrelli N, Rosset F, Mastorino L, Paolo D, Bocchino PP, De Filippo O, Ribero S, De Ferrari G, Quaglino P. Boskovic S, et al. Among authors: ribero s. Expert Opin Biol Ther. 2024 Apr;24(4):217-219. doi: 10.1080/14712598.2024.2337242. Epub 2024 Apr 1. Expert Opin Biol Ther. 2024. PMID: 38557408 No abstract available.
Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma.
Avallone G, Leo F, Astrua C, Mastorino L, Parente R, Grassi M, Fabrizio R, Ferraris A, Quaglino P, Ribero S. Avallone G, et al. Among authors: ribero s. Ital J Dermatol Venerol. 2024 Apr;159(2):215-216. doi: 10.23736/S2784-8671.24.07852-6. Epub 2024 Mar 4. Ital J Dermatol Venerol. 2024. PMID: 38436616 No abstract available.
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Di Nardo L, Antonelli F, Coscarella G, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Chiricozzi A, Peris K; MEDaCoTRA Study Group. Gori N, et al. Among authors: ribero s. J Eur Acad Dermatol Venereol. 2024 Feb 29. doi: 10.1111/jdv.19929. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38421043 No abstract available.
Safety of dupilumab in patients with cancer.
Macagno N, Mastorino L, Siliquini N, Santaniello U, Gelato F, Cavaliere G, Ortoncelli M, Ribero S, Quaglino P. Macagno N, et al. Among authors: ribero s. J Eur Acad Dermatol Venereol. 2024 Feb 19. doi: 10.1111/jdv.19873. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38372448 No abstract available.
283 results